Healthcare Realty Trust

Shares of Healthcare Realty Trust rose to a new 52-week high of $20.90, delivering a total return of 35.5% year-over-year and a gain of 25% year-to-date. The REIT has a market capitalization of $7.3 billion, has paid dividends for 34 years and currently yields 4.6%. A fair-value analysis suggests possible overvaluation. After Q1 results, Cantor Fitzgerald raised its price target to $22 (overweight); the company also secured a $400 million term loan facility (extendable) and placed $600 million of exchangeable senior notes due 2032. » More on de.investing.com

Healthcare Realty reported same‑store cash‑NOI growth of 6.9% in Q1 and normalized FFO of $0.41 per share; revenues of $267.6 million missed expectations. Management raised the full‑year normalized FFO outlook to $1.59–$1.65 and lifted the cash‑NOI growth range to 3.75–4.75%. Operationally, occupancy and tenant retention improved, the company closed numerous new and renewal leases, executed opportunistic share repurchases of $100 million and maintains liquidity of about $1.2 billion. Despite the healthy position, an upcoming $600 million bond maturity in August remains a watch item; the board approved a quarterly dividend of $0.24. » More on de.investing.com

Healthcare Realty Trust reported normalized FFO of $1.61 for 2025 and same-store NOI growth of 4.8% after completing an asset-management reset, $1.2 billion of non‑core asset sales and a $10 million G&A run‑rate reduction. Management says balance‑sheet repair is largely complete with net debt/EBITDA about 5.4x, and it repurchased $50 million of stock in January with $450 million remaining authorization. For 2026 the company guides normalized FFO of $1.58–$1.64 (midpoint $1.61), expects same‑store cash NOI growth of 3.5–4.5%, plans to refinance a $600 million bond and launch a $600 million commercial paper program, and will prioritize redevelopments, selective buybacks and accretive JVs. » More on finance.yahoo.com